Vera Therapeutics Inc’s recently made public that its SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R unloaded Company’s shares for reported $0.44 million on Nov 11 ’25. In the deal valued at $29.06 per share,15,000 shares were sold. As a result of this transaction, Young Joseph R now holds 47,839 shares worth roughly $1.41 million.
Then, ENRIGHT PATRICK G bought 209,393 shares, generating $4,369,676 in total proceeds. Upon buying the shares at $20.87, the Director now owns 3,569,522 shares.
Before that, ENRIGHT PATRICK G bought 40,607 shares. Vera Therapeutics Inc shares valued at $907,635 were divested by the Director at a price of $22.35 per share. As a result of the transaction, ENRIGHT PATRICK G now holds 3,596,593 shares, worth roughly $105.96 million.
BofA Securities initiated its Vera Therapeutics Inc [VERA] rating to a Buy in a research note published on October 16, 2025; the price target was $48. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in early August from “an Outperform” to “a Peer perform”. Wolfe Research started covering the stock on February 04, 2025. It rated VERA as “an Outperform”.
Price Performance Review of VERA
On Monday, Vera Therapeutics Inc [NASDAQ:VERA] saw its stock jump 3.92% to $29.46. Over the last five days, the stock has gained 6.16%. Vera Therapeutics Inc shares have fallen nearly -40.40% since the year began. Nevertheless, the stocks have fallen -30.34% over the past one year. While a 52-week high of $51.27 was reached on 01/06/25, a 52-week low of $18.53 was recorded on 04/09/25.
Levels Of Support And Resistance For VERA Stock
The 24-hour chart illustrates a support level at 28.24, which if violated will result in even more drops to 27.02. On the upside, there is a resistance level at 30.29. A further resistance level may holdings at 31.12.
How much short interest is there in Vera Therapeutics Inc?
A steep rise in short interest was recorded in Vera Therapeutics Inc stocks on 2025-10-31, dropping by -0.68 million shares to a total of 9.26 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 9.94 million shares. There was a decline of -7.33%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 28, 2025 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $58 price target.
